Artificial intelligence (AI)-assisted methodologies are increasingly reshaping early-stage drug discovery by integrating data-driven machine learning models with structure-based molecular modeling approaches. In the present study, seven newly synthesized sulfur-containing phenolic esters incorporating diethyl dithiocarbamate moieties were investigated as potential inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase, a clinically validated anticancer target. The compounds were synthesized via O-chloroacetylation of phenolic substrates followed by nucleophilic substitution with sodium diethyl dithiocarbamate, affording mono-, di-, and tri-substituted derivatives with increasing structural complexity. Molecular descriptors were calculated using RDKit, and a Random Forest classifier was developed based on a curated dataset of experimentally validated EGFR inhibitors and non-inhibitors. The model demonstrated strong predictive capability, achieving a cross-validated ROC-AUC of approximately 0.87, indicating reliable discrimination between active and inactive compounds. Feature importance analysis revealed that aromatic ring count, sulfur atom content, lipophilicity (LogP), and carbonyl functionality were the most influential contributors to predicted activity, underscoring the structural relevance of sulfur-rich fragments. Structure-based molecular docking against the EGFR kinase domain (PDB ID: 1M17) produced binding energies ranging from −6.8 to −8.9 kcal/mol. Tri-substituted derivatives exhibited enhanced ATP-binding pocket occupancy, favorable hydrogen bonding with hinge-region residues, and extensive hydrophobic interactions compared to mono- and di-substituted analogues. ADMET predictions suggested acceptable drug-likeness for mono- and di-derivatives, whereas tri-substituted compounds displayed slightly elevated molecular weight and lipophilicity but superior predicted affinity. Overall, the integration of machine learning prioritization with docking-based validation identifies tri-substituted sulfur-rich phenolic esters as promising lead scaffolds for further optimization toward potent and selective EGFR-targeted anticancer agents.